Safety of high doses of somatostatin analogs in well differentiated NENs in elderly
Massimiliano Cani(Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo), Giuseppe Badalamenti(University of Palermo), Salvatore Tafuto(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Sara Massironi(Azienda Ospedaliera San Gerardo), Anna La Salvia(Ospedale San Luigi Gonzaga), Francesco Gelsomino(Azienda USL di Bologna), Davide Campana(University of Bologna), Manuela Albertelli(Ospedale Policlinico San Martino), Sara Pusceddu(Fondazione IRCCS Istituto Nazionale dei Tumori), Toni Ibrahim(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Maria Rinzivillo(Sapienza University of Rome), Daniele Fanale(University of Palermo), Lorena Incorvaia(University of Palermo), Ida De Luca(University of Palermo), Giuseppe Lamberti(Dana-Farber Cancer Institute), V. Bazan(University of Palermo), Antonio Russo(University of Palermo), Ferdinando Riccardi(Ospedale Antonio Cardarelli), Giovanni Butturini(University of Verona), Antongiulio Faggiano(European Neuroendocrine Tumor Society)
Cited by 0
Related Papers
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
|JAMA|2010|1.4k
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization
|Nature Medicine|2011|637
Persistence of Increased Cardiovascular Risk in Patients with Cushing’s Disease after Five Years of Successful Cure
|The Journal of Clinical Endocrinology & Metabolism|1999|417